Ask Warren

OliX Pharmaceuticals

226950 · KOSDAQ · ₩226950 · 올릭스

₩90,600▼ ₩5,500 (5.72%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

20252024202320222021
Revenue₩15B₩5.7B₩17B₩9.3B₩3.7B
Cost of sales——₩0₩0—
Gross profit——₩17B₩9.3B—
Operating income−₩30B−₩31B−₩18B−₩22B−₩25B
Net income−₩16B−₩41B−₩19B−₩22B−₩30B
Net income to shareholders−₩16B−₩41B−₩19B−₩19B−₩30B

Balance sheet

20252024202320222021
Total assets₩195B₩71B₩103B₩133B₩87B
Current assets₩141B₩16B₩32B₩65B₩52B
Cash and equivalents₩6.4B₩3.9B₩12B₩4.9B₩34B
Total liabilities₩45B₩53B₩52B₩66B₩67B
Current liabilities₩21B₩30B₩6.6B₩40B₩40B
Borrowings₩22B₩38B₩35B₩39B₩36B
Total equity₩150B₩18B₩50B₩66B₩19B
Shareholders' equity₩149B₩18B₩50B₩66B₩19B

Cash flow

20252024202320222021
Cash from operations−₩16B−₩28B−₩21B−₩31B−₩19B
Free cash flow−₩16B−₩28B−₩21B−₩31B−₩19B

Consolidated where available. Amounts in won.

Also known as: OliX Pharmaceuticals / 올릭스 / 226950 / KRX:226950

Source: KRX statistical information